2014, Number 610
<< Back Next >>
Rev Med Cos Cen 2014; 71 (610)
Factores pronosticos basados en el estudio anatomopatológico de melanoma ocular
Orozco-Cárdenas A, Liu-Wu YC
Language: Spanish
References: 15
Page: 185-189
PDF size: 208.53 Kb.
ABSTRACT
Ocular melanoma is the
neoplasm transformation of
melanocytes from the uvea,
although it is a rare cancer,
“is the primary malignant
intraocular tumor more
common in adults and has a
high incidence of metastasis”.
“The investigation of ocular
melanoma prognostic factors
is important for patient
management and to understand
the biological processes that
influence the ability of tumors to
metastasize hematogenously”.
The ocular melanoma
prognosis depends mainly on
their clinical characteristics
and histopatológicas.
REFERENCES
Anónimo: Histopathologic characteristics of uveal melanoma in eyes enucleated from COMS (COLLABORATIVE OCULAR CHENG, OROZCO: FACTORES PRONOSTICOS DE MELANOMA OCULAR 189 MELANOMA STUDY) report nº.6 Am J Ophthalmol 1998; 125:745- 766.
Davidorf FH. The melanoma controversy. A comparison of choroidal, cutaneous and iris melanomas. Surv. Ophtalmol 1981;25:373-377.
Donoso LA, Shields JA, Augsburger JJ, Orth DH, Johnson P. Metastatic uveal melanoma: diffuse hepatic metastasis in a patient with concurrent normal serum enzymes and liver scan. Arch Ophthalmol 1985;103:799.
Eskelin S, Pyrhonen S, Summanen P. Screening for metastatic malignant melanoma of the uvea revisited. Cancer 1999;85:1151-1159.
Gamel JW , McLean IW, McCurdy JB. Biologic distinctions between cure and time to death in 2892 patients with intraocular melanoma. Cancer 1993;71:2299.
Gragoudas E, Li W, Goitein M, Lane AM, Munzenrider JE, Egan KM. Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol 2002;120:1665-1671
Gunduz K, Shields JA, Shields CL Plaque radiotherapy of melanoma predominant ciliary body involvement. Arch Ophthalmol 1999;117:170-177.
Jensen OA. Malignant melanomas of the uvea in Denmark 1943-1952: A clinical, histopathological and prognostic study. Acta Ophthalmol (Suppl) 1993;75:17-78.
Kumar, Cotran, Robbins. Neoplasias (Carcinogenesis: Bases Moleculares del cáncer). En: Patología Humana de Robbins (7ª edición en español). Madrid: Elservier España SA, 2003; 55: 1437-1439.
McLean IW, Foster WE, Zimmerman LE. Modifications of Callender’s classification of uveal melanoma the Armed Forced Institute of Pathology. Am J Ophthalmol 1983;96:502-509.
McLean IW, Foster WD, Zimmerman LE. Uveal melanoma: Location, size, cell type, an enucleation as risk factors in metastasis. Hum Pathol 1982;13:123.
Rones B, Zimmerman L. The prognosis of primary tumors of the iris treated by iridectomy. Arch Ophtahlmol 1958;60:193-205.
Scheidler J, Leinsinger G, Kirsch CM, Scheiffarth OF, Stefani FH, Riedel KG. Immunoimaging of choroidal melanoma: Assessment of its diagnostic accuracy and limitations in 101 cases. Br J Ophthalmol 1992;76:457-460.
Seddon JM, Albert DM, Lavin PT, Robinson N. A prognostic factor study of disease-free interval and survival following enucleation for uveal melanoma. Arch Ophthalmol 1983;101:1894-1899.
Singh AD, Shields CL, Shields JA. Intraocular tumors. En: Gospodarowicz MK et al (eds). Prognostic factors in cancer. UICC. 2ª ed. Nueva Cork: Wiley-Liss, 2001:647-669.